Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

NRX paid pill tracker $360,000 in consulting fees supposedly to research inhaler technology. Zachary Javitt (JJ 31 yr old son signed contracts). The company is a startup by the son focusing on tracking compliance of medications. He isCEO of pilltracker. ZERO EXPERIENCE AS CONSULTANT TO INHALERS.

The son also received hourly salary from NRX for IT consulting totalling about $88,000 since CA signed.

What legitimate CEO would hire a consultant (your son) with zero experience in the field for a potential goldmine drug you are researching? What does pill tracker have to do with the study and EUA?

~ CA_Newby, Y@h00 RLFTF finance conversations

Replies:

Basically since the CA was signed, JJ funneled about $460,000 to his son Zachary. No wonder NRX doesn't want to open the books to audit. They won't be a report or anything useful from the $360,000 given to pill tracker for research on inhalers for aviptadil. They won't be able show show any meaningful work product and the whole transaction reeks of bad intentions.

The hourly consulting work his son received totalling $88,000. Seriously what was necessary that your own internal IT company couldn't perform. He doesn't have any specialty training for IT work.

~ CA_Newby, Y@h00 RLFTF finance conversations

Source is SEC documents NRX filed in June 2021.

~ CA_Newby, Y@h00 RLFTF finance conversations